American Skullcap — Hermetica Encyclopedia
Herb · European

American Skullcap (Scutellaria lateriflora)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

American skullcap's primary bioactive compounds—baicalin, scutellarin, and wogonoside—modulate GABAergic signaling, reduce neuroinflammation via NF-κB inhibition, and exhibit antioxidant activity through flavonoid-mediated free radical scavenging. A 2014 crossover study published in Alternative Therapies in Health and Medicine found that acute doses of S. lateriflora significantly enhanced global mood without reducing energy or cognition, with peak anxiolytic effects observed at 350 mg of whole-herb extract.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerb
GroupEuropean
Evidence LevelPreliminary
Primary Keywordskullcap benefits
Skullcap close-up macro showing natural texture and detail — rich in stress, sleep, brain
American Skullcap — botanical close-up

Health Benefits

**Anxiolytic and Stress Reduction**
Baicalin and baicalein bind to GABA-A receptors as positive allosteric modulators, producing calming effects comparable to mild benzodiazepine-like activity without significant sedative burden at typical doses.
**Sedative and Sleep Support**
Scutellarin and wogonoside contribute to sedative activity by dampening central nervous system excitability, supporting sleep onset in individuals with mild insomnia when used as evening preparations.
**Neuroprotection**
Baicalin crosses the blood-brain barrier and inhibits NF-κB-mediated neuroinflammatory cascades, with preclinical studies demonstrating protection against oxidative neuronal injury in rodent models.
**Antioxidant Activity**
Total flavonoid content averaging over 1,071 mg per 100 g dry weight provides robust free radical scavenging capacity, with in vitro DPPH assays confirming significant antioxidant potency comparable to established botanical antioxidants.
**Addiction and Withdrawal Support**
Traditional Appalachian herbalism and modern naturopathic practice employ skullcap to ease nervous system dysregulation during withdrawal from alcohol and sedative-hypnotic drugs, attributed to GABAergic modulation by baicalin.
**Anti-inflammatory Effects**
Wogonoside and scutellarein inhibit pro-inflammatory cytokine release including TNF-α and IL-6 in macrophage cell models, suggesting systemic anti-inflammatory utility beyond the central nervous system.
**Hepatoprotective Potential**
Baicalin has demonstrated liver-protective effects in preclinical models by reducing lipid peroxidation and supporting antioxidant enzyme activity, though direct human hepatoprotection data for S. lateriflora specifically remains limited.

Origin & History

Skullcap growing in Europe — natural habitat
Natural habitat

Scutellaria lateriflora is native to eastern North America, ranging from the Appalachian Mountains through the eastern United States and into southern Canada, where it grows in moist woodlands, stream banks, and shaded meadows. The plant thrives in rich, well-drained loamy soils with partial to full shade and was historically wildcrafted by Indigenous peoples across the Algonquin, Cherokee, and Iroquois nations. Commercial cultivation now occurs in temperate regions of North America and Europe, with aerial parts harvested during flowering for maximal flavonoid content.

Scutellaria lateriflora has been employed as a medicinal nervine by multiple Indigenous North American peoples for centuries, with Cherokee healers using root infusions to promote menstruation, treat diarrhea, and stimulate breast milk production, while Iroquois and Algonquin traditions valued the aerial parts for nervous system calming and ceremonial ritual preparation. The herb entered Euro-American botanical medicine in the late 18th century and was prominently featured in the Eclectic Medical movement of the 19th century—physicians such as William Cook and John King praised it as 'the most reliable nervine tonic' for neurasthenia, chorea, and delirium tremens. By the early 20th century it appeared in the United States Pharmacopoeia and National Formulary, with Appalachian folk healers continuing to employ it as a critical component of withdrawal and 'nerve tonic' formulations through the 20th century. The genus name Scutellaria derives from the Latin scutella (small dish), referencing the dish-shaped calyx appendage, while the species epithet lateriflora describes the characteristic lateral flowering habit along stem nodes.Traditional Medicine

Scientific Research

The clinical evidence base for Scutellaria lateriflora is limited but gradually expanding, comprising primarily small pilot trials, crossover human studies, and a substantial body of in vitro and rodent preclinical research. The highest-quality human evidence is a 2014 randomized, double-blind, crossover trial (n=43) by Wolfson and Hoffman published in Alternative Therapies in Health and Medicine, which demonstrated statistically significant improvements in global mood and anxiety measured by visual analogue scales following acute 350 mg doses of whole-herb S. lateriflora extract. An earlier 2003 pilot study (n=19) by Wolfson et al. similarly reported anxiolytic effects without cognitive impairment, though its small size and lack of placebo washout limit conclusions. Preclinical pharmacological studies robustly support the GABAergic and anti-inflammatory mechanisms, but dose-response curves, pharmacokinetic parameters, and long-term safety data in humans remain inadequately characterized.

Preparation & Dosage

Skullcap steeped as herbal tea — pairs with American skullcap is commonly combined with valerian root (Valeriana officinalis) and passionflower (Passiflora incarnata) in nervine formulas, where complementary GABAergic mechanisms—valerian's valerenic acid inhibiting GABA transaminase and passionflower's chrysin acting at benzodiazepine sites—may produce additive sedative and anxiolytic effects without individual dose escalation. Pairing skullcap with adaptogenic herbs such as
Traditional preparation
**Dried Aerial Parts (Tea/Infusion)**
1–2 g of dried herb steeped in 250 mL hot water for 10–15 minutes, taken 2–3 times daily; traditional Appalachian preparation method
**Fluid Extract (1
2–4 mL taken up to three times daily; preserves full-spectrum flavonoid profile including baicalin and scutellarin
1)**: .
**Tincture (1
2–4 mL (approximately 40–80 drops) up to three times daily; standard phytopharmaceutical preparation
5 in 40–60% ethanol)**: .
**Standardized Capsules/Tablets**
350–500 mg whole-herb extract per dose, 1–3 times daily; the 350 mg dose demonstrated anxiolytic efficacy in the 2014 Wolfson crossover RCT
**Standardization Note**
000 mg per 100 g dry weight
Commercial extracts are frequently standardized to baicalin content (minimum 4–9% baicalin by HPLC); total flavonoid content of quality material should exceed 1,.
**Timing**
For sleep and relaxation, evening or pre-sleep dosing is traditional and mechanistically appropriate given GABAergic activity.
**Adulteration Warning**
Commercial preparations are frequently adulterated with Teucrium species (germander), which carry hepatotoxic diterpenoids; authentication via DNA barcoding or validated HPLC fingerprinting is recommended.

Nutritional Profile

Scutellaria lateriflora is not a significant source of macronutrients or conventional micronutrients in supplemental doses. Its pharmacological relevance is driven entirely by its phytochemical profile: total flavonoid content averages 1,071.85 mg per 100 g dry weight in commercial preparations, with scutellarin at approximately 511.32 mg/100 g and wogonoside at approximately 434.09 mg/100 g as dominant metabolites. Baicalin is consistently identified as the single most abundant individual flavonoid by chromatographic peak area, accompanied by lateriflorin, ikonnikoside, scutellarein 7-O-glucuronide, baicalein, wogonin, and 5,6,7-trihydroxyflavanone 7-O-glucuronide. Minor constituents include endogenous melatonin, serotonin, and trans-verbascoside (a phenylethanoid glycoside with antioxidant properties). Flavonoid bioavailability is enhanced by gut microbial hydrolysis of glucuronide conjugates to their active aglycone forms, and lipid co-administration may modestly improve absorption of the more lipophilic aglycones such as baicalein and wogonin.

How It Works

Mechanism of Action

The dominant flavonoid glycoside baicalin and its aglycone baicalein act as positive allosteric modulators at GABA-A receptors, particularly at benzodiazepine-binding sites, increasing chloride ion influx and reducing neuronal excitability in limbic and cortical circuits. Baicalin and wogonoside additionally inhibit the IκB kinase complex, preventing nuclear translocation of NF-κB and downstream transcription of pro-inflammatory mediators including COX-2, TNF-α, and interleukins-1β and -6. The plant's flavonoids also scavenge reactive oxygen species directly and upregulate endogenous antioxidant enzymes—superoxide dismutase and glutathione peroxidase—via Nrf2/ARE pathway activation observed in hepatocyte and neuronal cell lines. Melatonin and serotonin, identified as minor constituents, may contribute secondary chronobiotic and mood-modulatory effects, though their bioavailability from oral plant preparations has not been rigorously quantified.

Clinical Evidence

The most substantive clinical trial to date enrolled 43 healthy volunteers in a crossover design assessing single doses of 100 mg, 200 mg, and 350 mg of S. lateriflora whole-herb extract versus placebo, finding dose-dependent improvements in global mood on visual analogue scales without measurable cognitive sedation or performance decrements. A secondary crossover study corroborated anxiolytic effects with minimal side effects at acute doses, though neither trial assessed chronic supplementation, disorder-specific outcomes, or long-term safety endpoints. No large-scale randomized controlled trials (RCTs) have evaluated skullcap for clinical anxiety disorders, insomnia diagnoses, or addiction treatment by DSM criteria. Overall clinical confidence is low-to-moderate: the mechanistic plausibility is strong, traditional use is well-documented, but the evidence base requires larger, longer, and more rigorously controlled trials before definitive therapeutic claims can be made.

Safety & Interactions

At typical supplemental doses (350–1,000 mg whole herb per day), S. lateriflora is generally well-tolerated in healthy adults, with adverse effects limited to mild drowsiness, dizziness, and occasional gastrointestinal discomfort reported in human pilot trials. The most clinically significant safety concern is hepatotoxicity, which has been documented in case reports but is now largely attributed to adulteration with Teucrium species rather than genuine S. lateriflora; nonetheless, individuals with pre-existing liver disease should use caution and ensure product authentication. Pharmacodynamic interactions are theoretically relevant with CNS depressants—including benzodiazepines, barbiturates, opioid analgesics, alcohol, and sedative antihistamines—due to additive GABAergic potentiation, and patients taking these agents should consult a physician before use. Skullcap is not recommended during pregnancy (traditional emmenagogue use raises theoretical uterotonic concern) or lactation given insufficient safety data, and no established maximum safe dose has been defined through formal toxicological studies in humans.

Drug & Supplement Interactions

4 documented interactions for American Skullcap. Click any row to read the full explanation. Always consult your healthcare provider before combining supplements with medications.

Moderate4
  • Alprazolam

    Skullcap adds to Xanax sedation effects.

    What to do: Use caution. Inform prescriber about herbal use.

    Timing: Caution with sedating botanicals. Valerian, kava, passionflower, and hops all enhance GABA activity — the same pathway Alprazolam acts on. This can cause excessive sedation. If using calming herbs, take them at a different time and start with very low doses. Stimulating adaptogens are safer with benzodiazepines.

    Full interaction details →
  • Lorazepam

    Skullcap adds to Ativan sedation.

    What to do: Use caution.

    Timing: Caution with sedating botanicals. Valerian, kava, passionflower, and hops all enhance GABA activity — the same pathway Lorazepam acts on. This can cause excessive sedation. If using calming herbs, take them at a different time and start with very low doses. Stimulating adaptogens are safer with benzodiazepines.

    Full interaction details →
  • Zolpidem

    Skullcap with Ambien causes excessive sedation.

    What to do: Choose one approach for sleep.

    Timing: Take Zolpidem as prescribed. Skullcap can typically be taken with a meal at a different time. As a general rule, space botanicals 1-2 hours from prescription medications. St. John's Wort is the most interaction-prone botanical — it affects dozens of drugs via CYP enzyme induction. Always inform your prescriber about herbal supplements.

    Full interaction details →
  • Alcohol

    Skullcap intensifies alcohol sedation.

    What to do: Be aware of increased drowsiness.

    Timing: Skullcap can be taken with or around Alcohol. Many botanical compounds are better absorbed with food — especially fat-soluble ones like curcumin, which absorbs up to 2000% better with piperine and dietary fat. If the botanical has a strong taste, taking it during a meal helps mask it.

    Full interaction details →

Educational information only. Always consult a qualified healthcare provider before changing your supplement or medication regimen.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Scutellaria laterifloraAmerican skullcapBlue skullcapMad dog skullcapHelmet flowerHoodwort

Frequently Asked Questions

What is skullcap used for?
American skullcap (Scutellaria lateriflora) is primarily used as a nervine tonic to relieve anxiety, support sleep, and calm nervous system excitability. Its active flavonoids—particularly baicalin and scutellarin—modulate GABA-A receptors to reduce neuronal hyperexcitability, and traditional Appalachian herbalism also employed it to ease withdrawal symptoms from alcohol and sedative drugs.
Does skullcap actually work for anxiety?
A 2014 randomized, double-blind, crossover trial (n=43) found that single doses of 350 mg of whole-herb S. lateriflora extract produced statistically significant improvements in global mood and anxiety on visual analogue scales without reducing energy or cognitive performance. While this human evidence is promising, the trial was small and studied healthy volunteers rather than diagnosed anxiety disorder patients, so it should be viewed as preliminary support requiring confirmation in larger clinical studies.
How much skullcap should I take for sleep or anxiety?
Based on the most rigorous available human trial, 350 mg of standardized whole-herb extract demonstrated anxiolytic efficacy as a single acute dose. Traditional preparations use 1–2 g of dried herb as a tea or 2–4 mL of a 1:5 tincture taken 2–3 times daily, with evening dosing preferred for sleep support; however, no long-term dose-response study in humans has established a definitive optimal regimen.
Is skullcap safe, and can it damage the liver?
Genuine, authenticated Scutellaria lateriflora is generally considered safe at typical supplemental doses, with mild drowsiness and occasional gastrointestinal upset as the primary reported side effects. Hepatotoxicity cases historically attributed to skullcap are now believed to largely reflect adulteration with Teucrium (germander) species, which contain hepatotoxic diterpenoids; purchasing products verified by HPLC fingerprinting or DNA authentication substantially reduces this risk.
What is the difference between American skullcap and Chinese skullcap?
American skullcap (Scutellaria lateriflora) and Chinese skullcap (Scutellaria baicalensis) are related but distinct species with overlapping yet different phytochemical profiles and traditional applications. Both contain baicalin and baicalein as major bioactives, but Chinese skullcap root is far more extensively studied clinically and is used primarily for its anti-inflammatory, antiviral, and hepatoprotective effects in Traditional Chinese Medicine, whereas American skullcap aerial parts are specifically associated with nervine, anxiolytic, and sedative applications in Appalachian and North American herbalism.
Does skullcap interact with benzodiazepines or other anxiety medications?
Skullcap may potentiate the effects of benzodiazepines and other CNS depressants since both bind to GABA-A receptors, potentially increasing sedation or drowsiness. Concurrent use should be discussed with a healthcare provider to avoid excessive central nervous system depression. Clinical data on specific drug interactions is limited, so medical supervision is recommended when combining skullcap with prescription anxiolytics or sedatives.
What is the difference between skullcap extracts, dried herb, and tinctures in terms of potency?
Standardized extracts (typically standardized to baicalin content) offer consistent dosing and concentrated bioactive compounds, while dried herb infusions contain lower concentrations requiring larger volumes for effect. Tinctures provide intermediate potency and faster absorption compared to dried herb but less concentration than extracts. The choice depends on desired onset speed and convenience, though extracts are generally considered most potent per dose.
Who should avoid skullcap, and is it safe for pregnant or nursing women?
Skullcap is not recommended during pregnancy or lactation due to insufficient safety data and its GABAergic activity, which could affect fetal development or pass into breast milk. Individuals with liver disease or those taking hepatotoxic medications should consult a healthcare provider, as rare cases of liver injury have been associated with skullcap products (often contaminated with Teucrium species). People sensitive to plants in the Lamiaceae family may experience allergic reactions.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.